In vivo treatment with interleukin 2 reduces parasitemia and restores IFN-γ gene expression and T-cell proliferation during acute murin malaria

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 319, Issue 8, 1996, Pages 705-710

  Bernadette, L ^a   Kasper, L H ^a   Smith, K ^a   Haque, A ^a  

^a MAX PLANCK INST FÜR BIOLOGIE   (Germany)

Author keywords

Cytokine gene expression; Cytokine therapy; Parasitemia reduction; T cell expansion

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; ANTILYMPHOCYTE SERUM; CELL DIVISION; CONCANAVALIN A; FEMALE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-2; MALARIA; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM YOELII; T-LYMPHOCYTES;

EID: 0029842279     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)